World Pharma Market To Grow 6.7% CAGR To 2000

13 October 1996

By the year 2000, the world pharmaceutical market will reach a value of $379 billion (at manufacturers' selling prices), reflecting a compound annual growth rate of 6.7% during the period 1996-2000, according to a new report from the IMS Pharma Strategy Group, which covers virtually every market worldwide, or some 230 countries from Afghanistan to Zimbabwe. For 1995, the world market was valued at $284 billion.

Over the 1991-1995 period, the highest level of growth was evident in the Southeast Asian market, which grew by 10.2% CAGR, led by the buoyant economies of South Korea, Taiwan and Vietnam. Overall, the world drug market showed higher-than-average growth for the previous five-year period in 1995, 13.6%, partly due to governments relaxing cost controls in 1993-1994.

Growth is expected to be significantly slower in 1996 (2.9%) due to increased government cost-containment measures, including the introduction of reference pricing in most European countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight